Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 2
1995 2
1996 1
2000 1
2001 3
2002 2
2003 2
2004 3
2005 3
2006 3
2007 3
2008 7
2009 6
2010 5
2011 4
2012 10
2013 5
2014 4
2015 7
2016 9
2017 6
2018 1
2019 4
2020 1
2021 3
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

94 results

Results by year

Filters applied: . Clear all
Page 1
Long-term safety and efficacy of emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV-1 pre-exposure prophylaxis: week 96 results from a randomised, double-blind, placebo-controlled, phase 3 trial.
Ogbuagu O, Ruane PJ, Podzamczer D, Salazar LC, Henry K, Asmuth DM, Wohl D, Gilson R, Shao Y, Ebrahimi R, Cox S, Kintu A, Carter C, Das M, Baeten JM, Brainard DM, Whitlock G, Brunetta JM, Kronborg G, Spinner CD; DISCOVER study team. Ogbuagu O, et al. Among authors: asmuth dm. Lancet HIV. 2021 Jul;8(7):e397-e407. doi: 10.1016/S2352-3018(21)00071-0. Lancet HIV. 2021. PMID: 34197772 Clinical Trial.
Lessons from maraviroc clinical trials.
Troia-Cancio P, Asmuth DM. Troia-Cancio P, et al. Among authors: asmuth dm. Expert Rev Anti Infect Ther. 2011 Jun;9(6):649-51. doi: 10.1586/eri.11.52. Expert Rev Anti Infect Ther. 2011. PMID: 21692669 Review.
Peginterferon α-2a for the treatment of HIV infection.
Asmuth DM, Utay NS, Pollard RB. Asmuth DM, et al. Expert Opin Investig Drugs. 2016;25(2):249-57. doi: 10.1517/13543784.2016.1132699. Epub 2016 Jan 4. Expert Opin Investig Drugs. 2016. PMID: 26667398 Review.
Treatments for hepatitis B.
Asmuth DM, Nguyen HH, Melcher GP, Cohen SH, Pollard RB. Asmuth DM, et al. Clin Infect Dis. 2004 Nov 1;39(9):1353-62. doi: 10.1086/425010. Epub 2004 Oct 12. Clin Infect Dis. 2004. PMID: 15494913 Review.
Safety and efficacy of doravirine as first-line therapy in adults with HIV-1: week 192 results from the open-label extensions of the DRIVE-FORWARD and DRIVE-AHEAD phase 3 trials.
Orkin C, Molina JM, Cahn P, Lombaard J, Supparatpinyo K, Kumar S, Campbell H, Wan H, Teal V, Jin Xu Z, Asante-Appiah E, Sklar P, Teppler H, Lahoulou R; DRIVE-FORWARD and DRIVE-AHEAD collaborators. Orkin C, et al. Lancet HIV. 2024 Feb;11(2):e75-e85. doi: 10.1016/S2352-3018(23)00258-8. Epub 2023 Dec 20. Lancet HIV. 2024. PMID: 38141637 Clinical Trial.
Clinical features of microsporidiosis in patients with AIDS.
Asmuth DM, DeGirolami PC, Federman M, Ezratty CR, Pleskow DK, Desai G, Wanke CA. Asmuth DM, et al. Clin Infect Dis. 1994 May;18(5):819-25. doi: 10.1093/clinids/18.5.819. Clin Infect Dis. 1994. PMID: 7915548 Review.
94 results